Renaissance of contact x-ray therapy for treating rectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renaissance of contact x-ray therapy for treating rectal cancer

Published:2011-07 Issue:4 Volume:8 Page:483-492
ISSN:1743-4440
Container-title:Expert Review of Medical Devices
language:en
Short-container-title:Expert Review of Medical Devices

Author:

Gérard Jean-Pierre,Myint Arthur Sun,Croce Olivier,Lindegaard Jacob,Jensen Anie,Myerson Robert,Hannoun-Lévi Jean-Michel,Marcie Serge

Publisher

Informa UK Limited

Subject

Biomedical Engineering,General Medicine,Surgery

Link

http://www.tandfonline.com/doi/pdf/10.1586/erd.11.28

Reference29 articles.

1. Present status of radiation therapy in the conservative management of rectal cancer

2. Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique

3. Conservative Management of Rectal Adenocarcinoma by Radiotherapy

4. Factors affecting local control and survival after treatment of carcinoma of the rectum by endocavitary radiation: A retrospective study of 97 cases

5. Treatment of rectal adenocarcinoma with endocavitary and external beam radiotherapy: results for 199 patients with localized tumors

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetry and Monte Carlo modelling of the Papillon+ contact X-ray brachytherapy device;Brachytherapy;2024-09

2. Brachytherapy of rectal cancer: comparative characteristics of techniques (review);Koloproktologia;2023-09-21

3. In vivo dosimetry in cancer patients undergoing intraoperative radiation therapy;Physics in Medicine & Biology;2023-09-08

4. Endokavitäre Kontakttherapie vs. EBRT als Boost bei organerhaltender Strahlentherapie von T2–3-Rektumkarzinomen: Ergebnisse der OPERA-Studie;Strahlentherapie und Onkologie;2023-06-26

5. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial;The Lancet Gastroenterology & Hepatology;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3